Science Explorer Interactive view Map
Nonprofit · Ottawa · Canada

Canadian Agency for Drugs and Technologies in Health

World rank, all time
#19,941
of 42,892
Rank in Canada
#422
of 896
Research works
148
▼ 7% vs 2013–17
Citations
8.1k
54.5 per fractional work
Top-10% rate
22.2%
record average 16.5%
Open access
49%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.32× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 4.25× its world share, 1 worksImmunology and Micro…Neuroscience: 1.71× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.02× its world share, 0 worksPharmacology, Toxico…Engineering: 0.04× its world share, 0 worksEngineeringEnvironmental Science: 0.31× its world share, 0 worksEnvironmental ScienceMathematics: 0.76× its world share, 0 worksMathematicsPhysics and Astronomy: 0.05× its world share, 0 worksPhysics and AstronomyHealth Professions: 5.22× its world share, 3 worksHealth ProfessionsMedicine: 1.98× its world share, 8 worksMedicineVeterinary: 0.60× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.18× its world share, 0 worksBusiness, Management…Decision Sciences: 9.24× its world share, 2 worksDecision SciencesEconomics, Econometrics and Finance: 9.71× its world share, 4 worksEconomics, Econometr…Psychology: 0.69× its world share, 0 worksPsychologySocial Sciences: 0.24× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Economics, Econometrics and Finance, 9.7×. Every wedge is a field page.

Who are the top researchers at Canadian Agency for Drugs and Technologies in Health?

Ranked on the composite score, Laura Weeks, David Kaunelis and Kelly Farrah lead among researchers whose main affiliation is Canadian Agency for Drugs and Technologies in Health.

  1. 1 Laura Weeks Canada · #617 worldwide 4.7k citations · 96 works
  2. 2 David Kaunelis Canada · #13,779 worldwide 343 citations · 56 works
  3. 3 Kelly Farrah Canada · #54,869 worldwide 341 citations · 29 works
  4. 4 Alison Sinclair Canada · #285,066 worldwide 61 citations · 52 works
  5. 5 Michelle Mujoomdar Canada · #809,069 worldwide 15 citations · 19 works
  6. 6 Melissa Severn Canada · #859,608 worldwide 8 citations · 25 works
  7. 7 Karen Cimon Canada · #922,143 worldwide 50 citations · 78 works
  8. 8 Bernice Tsoi Canada · #1,167,424 worldwide 6 citations · 31 works
  9. 9 Charlotte Wells Canada · #1,556,200 worldwide 5 citations · 18 works
All ranked researchers at Canadian Agency for Drugs and Technologies in Health

Which keywords describe research at Canadian Agency for Drugs and Technologies in Health?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, COVID-19, Medical Education, Evidence-Based Practice, Clinical Trials and Pandemic.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 10 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 10 words, with their numbers
  1. Quality of Life4▲ 13×6 topics
  2. Cost-effectiveness Analysis4▲ 200×1 topic
  3. Health Utility Measures4▲ 200×1 topic
  4. COVID-192▲ 7.3×8 topics
  5. Evidence-Based Practice1▲ 49×3 topics
  6. Medical Education1▲ 26×4 topics
  7. Pandemic1▲ 5.8×6 topics
  8. Clinical Trials1▲ 8.4×6 topics
  9. Clinical Outcomes1▲ 23×2 topics
  10. Healthcare1▲ 4.5×5 topics

Which research topics does Canadian Agency for Drugs and Technologies in Health publish most on?

By volume in 2022–2025: Health Systems, Economic Evaluations, Quality of Life, Academic Publishing and Open Access, Biosimilars and Bioanalytical Methods and Health Sciences Research and Education.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 4 works
  2. 2 Academic Publishing and Open Access Information Systems and Management 1 works
  3. 3 Biosimilars and Bioanalytical Methods Immunology 1 works
  4. 4 Health Sciences Research and Education General Health Professions 1 works
  5. 5 Health Policy Implementation Science General Health Professions 1 works
  6. 6 Meta-analysis and systematic reviews Statistics, Probability and Uncertainty 0 works
  7. 7 Pharmaceutical Economics and Policy Economics and Econometrics 0 works
  8. 8 Neurological Disorders and Treatments Neurology 0 works
  9. 9 Healthcare cost, quality, practices General Health Professions 0 works
  10. 10 COVID-19 Clinical Research Studies Infectious Diseases 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available48.9%not open51.1%

World: 28% of research is openly available.

with international co-authors24.9%domestic only75.1%

World: 19% is written across borders.

How has Canadian Agency for Drugs and Technologies in Health's research output changed?

Output in 2018–2022 was 7% lower than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Ottawa

All research institutions in Ottawa

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.